Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3

Watchlist Manager
Profarma Distribuidora de Produtos Farmaceuticos SA Logo
Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
Watchlist
Price: 7.74 BRL 2.38% Market Closed
Market Cap: 958.3m BRL
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one PFRM3 stock under the Base Case scenario is 29.48 BRL. Compared to the current market price of 7.74 BRL, Profarma Distribuidora de Produtos Farmaceuticos SA is Undervalued by 74%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PFRM3 Relative Value
Base Case
29.48 BRL
Undervaluation 74%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.1
P/S
P/S
Price to Sales
0.1
vs History
41
vs Industry
92
Median 3Y
0.1
Median 5Y
0.1
Industry
2.4
More Details
8
P/E
P/E
Price to Earnings
8
vs History
46
vs Industry
44
Median 3Y
7.7
Median 5Y
7.9
Industry
22.5
More Details
2.6
P/OCF
P/OCF
Price to OCF
2.6
vs History
44
vs Industry
54
Median 3Y
1.8
Median 5Y
2.3
Industry
14.4
More Details
5.6
P/FCFE
P/FCFE
Price to FCFE
5.6
vs History
30
vs Industry
37
Median 3Y
5.5
Median 5Y
-1.4
Industry
20.4
More Details
0.7
P/B
P/B
Price to Book Value
0.7
vs History
6
vs Industry
73
Median 3Y
0.5
Median 5Y
0.5
Industry
2.2
More Details
0.1
EV/S
EV/S
Enterprise Value to Sales
0.1
vs History
65
vs Industry
90
Median 3Y
0.1
Median 5Y
0.1
Industry
2.6
More Details
0.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.9
vs History
66
vs Industry
82
Median 3Y
0.9
Median 5Y
1
Industry
5.2
More Details
2.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
2.9
vs History
58
vs Industry
51
Median 3Y
2.9
Median 5Y
3.1
Industry
11.9
More Details
4.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
4.7
vs History
65
vs Industry
47
Median 3Y
4.6
Median 5Y
4.9
Industry
16.3
More Details
3.9
EV/OCF
EV/OCF
Enterprise Value to OCF
3.9
vs History
47
vs Industry
53
Median 3Y
3.5
Median 5Y
3.9
Industry
14.5
More Details
5.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
5.8
vs History
31
vs Industry
42
Median 3Y
4.3
Median 5Y
4.3
Industry
17.9
More Details
0.4
EV/IC
EV/IC
Enterprise Value to IC
0.4
vs History
36
vs Industry
77
Median 3Y
0.4
Median 5Y
0.4
Industry
1.9
More Details

Multiples Across Competitors

PFRM3 Competitors Multiples
Profarma Distribuidora de Produtos Farmaceuticos SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
BR
Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
949m BRL 0.1 8 2.9 4.7
US
Mckesson Corp
NYSE:MCK
82.4B USD 0.2 25 16 18.3
US
Amerisourcebergen Corp
LSE:0HF3
55.6B USD 0.2 29.3 13.5 17.7
US
Cencora Inc
NYSE:COR
56.1B USD 0.2 29.5 13.6 17.8
US
Cardinal Health Inc
NYSE:CAH
35B USD 0.2 22.4 12.3 16.2
AU
Sigma Healthcare Ltd
ASX:SIG
32.9B AUD 6.7 -2 376.8 1 524.1 1 524.1
CN
Huadong Medicine Co Ltd
SZSE:000963
74.4B CNY 1.8 20.9 16.4 16.4
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
70.5B CNY 0.3 16.2 10.7 10.7
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
US
Henry Schein Inc
NASDAQ:HSIC
8.2B USD 0.6 21.2 10.3 14.3
AU
EBOS Group Ltd
OTC:EBOSY
8.2B USD 1 50.9 30.4 30.4

See Also

Summary
PFRM3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
PFRM3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PFRM3 stock valuation using valuation multiples.
Wall Street Estimates
PFRM3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PFRM3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 274,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.